Y One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the Iris® Registry
AuthID
P-00Z-3T5
P-00Z-3T5
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service